IDO1 and neoplasm: Therefore, focusing on the differential expression of IDO1 in different tumors and its prognosis in comparison with combination drug therapy, IDO1 could be a good immune checkpoint to start developing IDO1 inhibitor-related therapeutics to improve anti-tumor efficacy and patient survival.